Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 19, 2019 Off

Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy

By BusinessWire

Bristol-Myers Squibb will maintain strategic presence in Italy through ongoing development and commercialization of new medicines Catalent will continue to…

June 19, 2019 Off

Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy

By BusinessWire

Bristol-Myers Squibb will maintain strategic presence in Italy through ongoing development and commercialization of new medicines Catalent will continue to…

June 19, 2019 Off

Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy

By BusinessWire

Bristol-Myers Squibb will maintain strategic presence in Italy through ongoing development and commercialization of new medicines Catalent will continue to…

June 19, 2019 Off

Global Gastrointestinal Stromal Tumor (GIST) Market Spotlight 2017-2026 – Clinical Trial Activity in the GIST Space is Dominated by Completed Trials – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Gastrointestinal Stromal Tumor (GIST)” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers…

June 19, 2019 Off

Global Uterine Cancer Market Spotlight 2017-2026: Key Pipeline Drugs, Clinical Trials, Patent Information, Disease Incidence Forecasts and Licensing and Acquisition Deals – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Uterine Cancer” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the uterine…

June 19, 2019 Off

Global Uterine Cancer Market Spotlight 2017-2026: Key Pipeline Drugs, Clinical Trials, Patent Information, Disease Incidence Forecasts and Licensing and Acquisition Deals – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Uterine Cancer” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the uterine…

June 19, 2019 Off

AstraZeneca and Merck’s LYNPARZA® (olaparib) Approved in Japan as First-Line Maintenance Therapy in Patients with BRCA-Mutated Advanced Ovarian Cancer

By BusinessWire

LYNPARZA is the Only PARP Inhibitor Approved in Japan KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–AstraZeneca and Merck (NYSE: MRK), known as MSD…

Global Peripheral T-Cell Lymphoma (PTCL) Market Spotlight 2018-2026
June 19, 2019 Off

Global Peripheral T-Cell Lymphoma (PTCL) Market Spotlight 2018-2026

By BusinessWire

Estimation says that in 2017, there were approximately 19,950
incident cases of peripheral T-cell lymphoma (PTCL) worldwide, and
forecasts that number to increase to 23,880 incident cases by 2026.

Parasitic Diseases Therapeutics Market Worth USD 1.79 Billion, at 5% CAGR During 2019-2023
June 19, 2019 Off

Parasitic Diseases Therapeutics Market Worth USD 1.79 Billion, at 5% CAGR During 2019-2023

By BusinessWire

Therapeutics Market by type (antiprotozoal therapeutics, anthelminthic
therapeutics, scabicides, and pediculicides therapeutics) and geographic
regions (Asia, ROW, North America, and Europe) is witnessed to
grow USD 1.79 billion, at a CAGR of 5% from 2019 to 2023”

Ironwood, Allergan with positive topline data from LINZESS testing in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
June 19, 2019 Off

Ironwood, Allergan with positive topline data from LINZESS testing in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)

By BusinessWire

– Phase IIIb study met all primary and secondary endpoints
with statistical significance and demonstrated that linaclotide improved
the overall abdominal symptoms of bloating, pain and discomfort in
adults with IBS-C –

Posts pagination

Previous 1 … 3,066 3,067 3,068 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine